Release Date: 27/07/18 10:46 Summary: Appendix 4C (Monthly Reporting) - June 2018 Price Sensitive: Yes Download Document 169.64KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status